SCHEMBL7840929

SCHEMBL7840929

O=C(O)/C(=C/c1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 4/20 0.75
AKR1C3 P42330 4/20 0.65
AKR1C2 P52895 3/20 0.63
PTGS2 P35354 2/20 0.61
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
POLB P06746 2/20 0.57
ALDH1A1 P00352 3/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7840931 1.00 AKR1C1 (0.75) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL39275 0.86 AKR1C1 (1.00) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL181529 0.86 AKR1C1 (1.00) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL290469 0.86 AKR1C1 (1.00) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL6513319 0.86 AKR1C1 (0.55) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL6513317 0.86 AKR1C1 (0.55) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL27448137 0.84 AKR1C1 (0.96) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL4463208 0.83 AKR1C1 (0.78) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL6384205 0.83 AKR1C1 (0.78) AKR1C1AKR1C3AKR1C2PTGS2KMT2A
SCHEMBL13092046 0.83 AKR1C1 (0.78) AKR1C1AKR1C3AKR1C2PTGS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed